T2 Biosystems, Inc. (NASDAQ:TTOO – Get Free Report) was the target of a large drop in short interest during the month of January. As of January 15th, there was short interest totalling 826,900 shares, a drop of 12.3% from the December 31st total of 942,500 shares. Based on an average daily volume of 1,080,000 shares, the short-interest ratio is currently 0.8 days. Approximately 6.6% of the company’s shares are short sold.
T2 Biosystems Price Performance
Shares of TTOO stock opened at $0.22 on Friday. The stock has a 50 day moving average price of $0.38 and a 200 day moving average price of $1.78. T2 Biosystems has a 52-week low of $0.21 and a 52-week high of $6.95.
Wall Street Analyst Weigh In
Separately, StockNews.com began coverage on shares of T2 Biosystems in a research report on Wednesday. They set a “sell” rating on the stock.
About T2 Biosystems
T2 Biosystems, Inc, an in vitro diagnostics company, develops and sells diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fluid, and urine.
Featured Stories
- Five stocks we like better than T2 Biosystems
- How to Capture the Benefits of Dividend Increases
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for T2 Biosystems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for T2 Biosystems and related companies with MarketBeat.com's FREE daily email newsletter.
